battle of glp-1 delivery technologies Disruptive Innovations Shaping the Landscape evaluate the pharmaceuticals company byetta

A successful lawsuit could lead to increased scrutiny of GLP-1 agonists and similar drugs, potentially affecting their availability and use

Microdosing GLP-1s for cosmetic weight loss: Patients are asking me about it, TV and online ads are promoting it, friends are speculating about whos doing it

The potency and duration of action of an N-(3-phenyl-1,2,4-thiadiazol-5-yl) piperazine analog, discovered through high-speed analog synthesis, were enhanced via structural optimization

GLP-1 is a naturally occurring hormone that influences our blood sugar levels, insulin levels, and feelings of hunger

Type 1 diabetes is unique amongst many of the chronic diseases where escalation of therapy does not routinely include the addition of alternative adjunctive pharmacotherapy